8-K
filed July 23, 2021, 7:59 PM ET
ticker INDP
CIK 0001857044
leadership
confidence high
sentiment neutral
materiality 0.30
Intec Parent appoints board, officers, and amends charter/bylaws
Indaptus Therapeutics, Inc.
- Appointed Hila Karah, Anthony Maddaluna, William Hayes, and Dr. Roger Pomerantz as directors; Pomerantz as Chairman.
- Jeffrey Meckler continues as director; officers: Meckler CEO, Nir Sassi CFO, Walt Linscott CBO.
- Board committees formed: Audit (Hayes chair, Pomerantz, Karah), Compensation (Maddaluna chair, Hayes), Nominating (Pomerantz chair, Maddaluna).
- Amended and restated certificate of incorporation and bylaws adopted effective July 23, 2021.
- Intec Israel authorized share capital: 17.5M ordinary shares, 7,370,883 outstanding (as of July 23, 2021).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Roger J. Pomerantz was appointed as Chairman at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Chairman
Exact text from the filing
Dr. Roger J. Pomerantz also was appointed as Chairman of the Company’s board of directors.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Walt Linscott was appointed as Chief Business Officer at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Chief Business Officer
Exact text from the filing
Walt Linscott Chief Business Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Nir Sassi was appointed as Chief Financial Officer at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
Nir Sassi Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William B. Hayes was appointed as Director at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jeffrey Meckler was appointed as Chief Executive Officer at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
Jeffrey Meckler Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Anthony J. Maddaluna was appointed as Director at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Roger J. Pomerantz was appointed as Director at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Hila Karah was appointed as Director at Indaptus Therapeutics, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.